Early analyst calls: DNA, JNJ

Posted Aug 15th 2008 7:20AM by Douglas McIntyreDouglas McIntyre RSS Feed
Filed under: Before the Bell, Analyst Upgrades and Downgrades, Johnson and Johnson (JNJ), Genentech Inc (DNA)

More

Goldman Sachs downgraded Daimler (NYSE: DAI) to Neutral from Buy, according to MarketWatch.

Citigroup downgraded Genentech (NYSE: DNA) to Hold from Buy, according to Briefing.com. The news service also writes that UBS downgraded Johnson & Johnson (NYSE: JNJ) to Hold from Buy.

Priceline.com (NASDAQ: PCLN) was raised to Buy at Citigroup, according to Briefing.com. The financial site also reports that Harman (NYSE: HAR) was cut to Neutral at Baird.

Tags: DAI, DNA, har, inthenews, JNJ, pcln

Symbol Lookup
IndexesChangePrice
DJIA+150.2510,058.64
NASDAQ+24.822,150.87
S&P 500+13.781,070.52

Last updated: February 10, 2010: 05:23 AM

Hot Stocks

DailyFinance Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    • My Portfolio
    • Create a New Portfolio

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines